| Literature DB >> 29854796 |
Xin Xu1,2, Zhen M Ou1, Christine D Wu1.
Abstract
This study aimed to investigate the effects of different microbial growth media on the laboratory assessment of antimicrobial activity of natural polyphenolic compounds. The inhibition of the tea polyphenol EGCG on growth of selected oral microorganisms was evaluated in complex media and a protein-free chemically defined medium (CDM). Other antimicrobial agents (polyphenolic grape seed extract, plant alkaloid berberine, methyl salicylate, and chlorhexidine gluconate) were also tested in the study. The presence of proteins and their effects on the antimicrobial activity of EGCG were investigated by the addition of BSA to the CDM. The MICs of EGCG against test oral microorganisms were 4 to 64 times higher in complex media than in CDM. The polyphenolic grape seed extract exhibited similar discrepancies. However, the MICs of the nonpolyphenolic compounds (berberine, methyl salicylate, and chlorhexidine) were not significantly different between the two growth media. The MIC of EGCG against S. mutans UA159 in CDM with added BSA was 16 times higher than that in CDM alone. Therefore, nonproteinaceous CDM should be used to avoid interference of proteins with the active ingredients when testing the antimicrobial activity of plant-derived polyphenolic compounds against microorganisms. This will also minimize the discrepancies noted in results obtained by different investigators.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29854796 PMCID: PMC5966681 DOI: 10.1155/2018/8308640
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Effects of EGCG and the other test agents on the growth of selected oral bacteria.
| Strains | MIC ( | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| EGCG | Grape seed extract | Berberine chloride | Methyl salicylate# | Chlorhexidine gluconate | ||||||
| CDM | BHI | CDM | BHI | CDM | BHI | CDM | BHI | CDM | BHI | |
|
| 78.1 | 625 | 125 | >500 | 125 | 125 | >3% | >3% | 2.5 | 5 |
| ATCC 25175 | ||||||||||
|
| 39.1 | 625 | 125 | >500 | 125 | 125 | >3% | >3% | 2.5 | 5 |
| UA159 | ||||||||||
|
| 78.1 | 625 | 62.5 | >500 | 125 | 250 | 3% | >3% | 5 | 5 |
| Ingbritt | ||||||||||
|
| ≤9.8 | 625 | >500 | >500 | 125 | 250 | 0.75% | >3% | 10 | 10 |
| ATCC 49818 | ||||||||||
|
| ≤9.8 | 312.5 | >500 | >500 | 125 | 250 | >3% | >3% | 10 | 10 |
| ATCC 10556 | ||||||||||
|
| 19.5 | 1250 | 62.5 | >500 | 62.5 | 125 | 3% | >3% | 5 | 5 |
| ATCC 6715 | ||||||||||
|
| 39.1 | 156.3 | 250 | >500 | 125 | 250 | 0.75% | 0.75% | 5 | 10 |
| ATCC 43718 | ||||||||||
|
| 39.1 | >1250 | 62.5 | >500 | 500 | >500 | >3% | >3% | 20 | 20 |
| ATCC 29212 | ||||||||||
#The unit of MIC values is % of methyl salicylate (vol/vol).
Figure 1The effects of different growth media on the antimicrobial efficacy of test compounds against selected oral microorganisms. The vertical lines represent the range of the fold change in MIC (complex medium versus CDM). Square dots represent the median fold change in MIC. The antimicrobial efficacy of EGCG and grape seed extract (GSE) was significantly reduced in complex medium, while the efficacy of berberine chloride (BBr), methyl salicylate (MS), and chlorhexidine gluconate (CHX) was not significantly influenced by the growth medium.
Effects of EGCG and the other test agents on the growth of selected Candida species in different growth media.
| Strains | MIC ( | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| EGCG | Grape seed extract | Berberine chloride | Methyl salicylate# | Chlorhexidine gluconate | ||||||
| RPMI 1640 | SDB | RPMI 1640 | SDB | RPMI 1640 | SDB | RPMI 1640 | SDB | RPMI 1640 | SDB | |
|
| 1250 | >1250 | >500 | >500 | >500 | 500 | 1.50% | 0.75% | 6.25 | 12.5 |
| SC5314 | ||||||||||
|
| 1250 | 1250 | >500 | >500 | 500 | 500 | 1.50% | 1.50% | 3.12 | 12.5 |
| ATCC 10231 | ||||||||||
|
| 312.5 | >1250 | >500 | >500 | 500 | 500 | 0.75% | 0.38% | 3.12 | 3.12 |
| ATCC 66032 | ||||||||||
|
| ≥1250 | 1250 | >500 | >500 | 125 | 125 | 3% | 0.75% | 1.56 | 0.78 |
| ATCC 13803 | ||||||||||
|
| 1250 | >1250 | >500 | >500 | >500 | 500 | 0.19% | 0.38% | 3.12 | 6.25 |
| ATCC 22019 | ||||||||||
|
| 156.3 | 1205 | >500 | >500 | 62.5 | 62.5 | 0.38% | 0.38% | 0.78 | 0.78 |
| ATCC 46764 | ||||||||||
|
| 78.1 | >1250 | >500 | >500 | 125 | 125 | 0.75% | 0.75% | 1.56 | 1.56 |
| ATCC 14243 | ||||||||||
#The unit of MIC values is % of methyl salicylate (vol/vol).
Effects of EGCG and the other test agents on the viability of selected oral bacteria.
| Strains | MBC ( | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| EGCG | Grape seed extract | Berberine chloride | Methyl salicylate# | Chlorhexidine gluconate | ||||||
| CDM | BHI | CDM | BHI | CDM | BHI | CDM | BHI | CDM | BHI | |
|
| 156.3 | 1250 | 500 | >500 | 125 | 125 | >3% | >3% | 5 | 10 |
| ATCC 25175 | ||||||||||
|
| 78.1 | 1250 | >500 | >500 | 125 | 125 | >3% | >3% | 5 | 10 |
| UA159 | ||||||||||
|
| 78.1 | 1250 | 500 | >500 | 250 | 250 | 3% | >3% | 5 | 20 |
| Ingbritt | ||||||||||
|
| ≤9.77 | 1250 | >500 | >500 | 250 | 250 | 0.75% | >3% | 10 | 10 |
| ATCC 49818 | ||||||||||
|
| 19.5 | >1250 | >500 | >500 | 125 | 250 | >3% | >3% | 10 | 10 |
| ATCC 10556 | ||||||||||
|
| 78.1 | >1250 | 125 | >500 | 62.5 | 125 | >3% | >3% | 5 | 5 |
| ATCC 6715 | ||||||||||
|
| 39.1 | 156.3 | >500 | >500 | 250 | 500 | 0.75% | 0.75% | 5 | 10 |
| ATCC 43718 | ||||||||||
|
| 625 | >1250 | >500 | >500 | >500 | >500 | >3% | >3% | 20 | 20 |
| ATCC 29212 | ||||||||||
#The unit of MBC/MFC values is % of methyl salicylate (vol/vol).
Effects of EGCG and the other test agents on the viability of selected Candida species in different growth media.
| Strains | MFC ( | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| EGCG | Grape seed extract | Berberine chloride | Methyl salicylate# | Chlorhexidine gluconate | ||||||
| RPMI 1640 | SDB | RPMI 1640 | SDB | RPMI 1640 | SDB | RPMI 1640 | SDB | RPMI 1640 | SDB | |
|
| >1250 | >1250 | >500 | >500 | >500 | >500 | 1.50% | 0.75% | 6.25 | 12.5 |
| SC5314 | ||||||||||
|
| >1250 | >1250 | >500 | >500 | >500 | >500 | 1.50% | 1.50% | 6.25 | 12.5 |
| ATCC 10231 | ||||||||||
|
| >1250 | >1250 | >500 | >500 | >500 | >500 | 0.75% | 0.38% | 3.12 | 6.25 |
| ATCC 66032 | ||||||||||
|
| >1250 | 1250 | >500 | >500 | 125 | 125 | 3% | 1.50% | 1.56 | 1.56 |
| ATCC 13803 | ||||||||||
|
| >1250 | >1250 | >500 | >500 | >500 | >500 | 0.19% | 0.38% | 3.12 | 12.5 |
| ATCC 22019 | ||||||||||
|
| >1250 | 1250 | >500 | >500 | 62.5 | 62.5 | 0.38% | 0.38% | 0.78 | 1.56 |
| ATCC 46764 | ||||||||||
|
| >1250 | >1250 | >500 | >500 | 125 | 125 | 0.75% | 0.75% | 1.56 | 1.56 |
| ATCC 14243 | ||||||||||
#The unit of MBC/MFC values is % of methyl salicylate (vol/vol).
Figure 2Effect of bovine serum albumin on the antimicrobial activity of EGCG against S. mutans UA159. A dose-dependent increase in the minimum inhibitory concentration (MIC) of EGCG was observed with the addition of BSA to the assay mixtures. MIC values were averages of three independent tests.